Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
or
Menu

Johnson & Johnson (JNJ)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 368,013,664
  • Shares Outstanding, K 2,682,902
  • Annual Sales, $ 81,581 M
  • Annual Income, $ 15,297 M
  • 60-Month Beta 0.68
  • Price/Sales 4.53
  • Price/Cash Flow 12.62
  • Price/Book 6.18

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 13 analysts offering recommendations.
Earnings Estimates - Current Qtr 03/31/19
See More
  • Average Estimate 2.07
  • Number of Estimates 8
  • High Estimate 2.15
  • Low Estimate 1.96
  • Prior Year 2.06
  • Growth Rate Est. (year over year) +0.49%

Price Performance

See More
Period Period Low Period High Performance
1-Month
134.27 +2.91%
on 02/21/19
140.00 -1.30%
on 03/12/19
+2.49 (+1.83%)
since 02/19/19
3-Month
121.00 +14.19%
on 12/24/18
140.00 -1.30%
on 03/12/19
+10.57 (+8.28%)
since 12/19/18
52-Week
118.62 +16.49%
on 05/29/18
148.99 -7.26%
on 12/04/18
+7.93 (+6.09%)
since 03/19/18

Most Recent Stories

More News
Adopt The Growth Mindset To Kickstart Your Success

DALLAS, TX / ACCESSWIRE / March 19, 2019 / Major Depressive Disorder on average affects over 16.1 million adults over the age of 18. If you are someone who feels lost, alone, or aimless, chances are the...

JNJ : 138.13 (+0.70%)
Johnson & Johnson to Host Investor Conference Call on First-Quarter Results

Johnson & Johnson (NYSE: JNJ) will host a conference call for investors at 8:30 a.m. (Eastern Time) on Tuesday, April 16th, to review first-quarter results. Joseph J. Wolk, Executive Vice President, Chief...

JNJ : 138.13 (+0.70%)
Global Nicotine Patch Market Outlook, 2019-2023 with Dr. Reddy's Laboratories, GlaxoSmithKline, Johnson & Johnson Services, Novartis, and Perrigo Company Dominating

The "Global Nicotine Patch Market 2019-2023" report has been added to ResearchAndMarkets.com's offering.

JNJ : 138.13 (+0.70%)
GSK : 40.43 (-0.15%)
Johnson & Johnson (JNJ) Stock Sinks As Market Gains: What You Should Know

Johnson & Johnson (JNJ) closed the most recent trading day at $137.35, moving -0.19% from the previous trading session.

JNJ : 138.13 (+0.70%)
Craft Earns ISO 17100:2015 Quality Certification

Craft Worldwide, the global content-production and adaptation unit of McCann Worldgroup, today announced that it has been certified to the ISO 17100:2015 standard for translation, transcreation, and multilingual...

IPG : 22.22 (+0.05%)
JNJ : 138.13 (+0.70%)
Barron's 400 ETF Finds Growth at a Reasonable Price Buys in Health Care, Industrials, Technology in Largest Rotation of Companies since Inception

The Barron's 400 ETF (NYSE Arca: BFOR), a smart beta exchange-traded fund that seeks to track the Barron's 400 Index (B400), has completed its semi-annual rebalance based on the reconstitution...

SBUX : 71.10 (+0.37%)
BMTC : 37.82 (-2.43%)
JNJ : 138.13 (+0.70%)
The Zacks Analyst Blog Highlights: Pfizer, Roche, Merck, Allergan and J&J

The Zacks Analyst Blog Highlights: Pfizer, Roche, Merck, Allergan and J&J

JNJ : 138.13 (+0.70%)
MRK : 81.72 (+0.45%)
AGN : 153.95 (+2.06%)
RHHBY : 33.7020 (-0.47%)
PFE : 42.20 (+0.93%)
CeQur Appoints Peter B. Luther to Board of Directors

CeQur® announced the appointment of Peter B. Luther to its board of directors, effective immediately. Luther is a 29-year veteran of the medical device and diagnostics, OTC drugs and consumer-packaged...

JNJ : 138.13 (+0.70%)
XARELTO® (rivaroxaban) Significantly Reduced the Risk of Overall Strokes and the Most Severe Strokes and Was Associated with Fewer Stroke-Related Deaths in the Real World Versus Warfarin in Patients with Nonvalvular Atrial Fibrillation

The Janssen Pharmaceutical Companies of Johnson & Johnson today announced results of a new real-world study, which found newly diagnosed patients with nonvalvular atrial fibrillation (NVAF) taking XARELTO®...

JNJ : 138.13 (+0.70%)
Pharma Stock Roundup: Regulatory Updates From MRK, PFE, J&J, AGN & Others

Regulatory updates from J&J (JNJ), Merck (MRK), Roche (RHHBY), Pfizer (PFE) and others.

MRK : 81.72 (+0.45%)
JNJ : 138.13 (+0.70%)
LLY : 126.13 (+0.71%)
AGN : 153.95 (+2.06%)
RHHBY : 33.7020 (-0.47%)
PFE : 42.20 (+0.93%)
BMY : 49.50 (-0.72%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 40% Buy with a Strengthening short term outlook on maintaining the current direction.

Longer term, the trend strength is Minimum.

See More Share

Trade JNJ with:

Business Summary

Johnson & Johnson is engaged in the research and development, manufacture and sale of a range of products in the healthcare field. The Company operates in three segments: Consumer, Pharmaceutical, and Medical Devices and Diagnostics. Its Consumer segment offers products for use in the baby care, skin...

See More

Key Turning Points

2nd Resistance Point 138.28
1st Resistance Point 137.73
Last Price 138.13
1st Support Level 136.67
2nd Support Level 136.16

See More

52-Week High 148.99
Last Price 138.13
Fibonacci 61.8% 137.39
Fibonacci 50% 133.81
Fibonacci 38.2% 130.22
52-Week Low 118.62

See More

Add Data Columns to this Table
Learn about our Custom Views
Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Read About Upcoming
Changes to This Feature
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar